Log In
Print this Print this

FYX-051, SK-0910

  Manage Alerts
Collapse Summary General Information
Company Sanwa Kagaku Kenkyusho Co. Ltd.
DescriptionXanthine oxidase inhibitor
Molecular Target
Mechanism of ActionXanthine oxidase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationHyperuricemia / gout
Indication DetailsTreat hyperuricemia/gout
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today